Exploring the immunomodulatory potential of Brahmi (Bacopa monnieri) in the treatment of invasive ductal carcinoma.

Anti-cancer activity Brahmi Plant Preparation (BPP) Immunomodulation Invasive Ductal Carcinoma (IDC) T helper 1 (TH1) cells

Journal

Medical oncology (Northwood, London, England)
ISSN: 1559-131X
Titre abrégé: Med Oncol
Pays: United States
ID NLM: 9435512

Informations de publication

Date de publication:
15 Apr 2024
Historique:
received: 04 02 2024
accepted: 19 03 2024
medline: 16 4 2024
pubmed: 16 4 2024
entrez: 15 4 2024
Statut: epublish

Résumé

Bacopa monnieri (L) Wettst, commonly known as Brahmi, stands as a medicinal plant integral to India's traditional medical system, Ayurveda, where it is recognized as a "medhya rasayana"-a botanical entity believed to enhance intellect and mental clarity. Its significant role in numerous Ayurvedic formulations designed to address conditions such as anxiety, memory loss, impaired cognition, and diminished concentration underscores its prominence. Beyond its application in cognitive health, Brahmi has historically been employed in Ayurvedic practices for the treatment of inflammatory diseases, including arthritis. In contemporary biomedical research, Bacopa monnieri can attenuate the release of pro-inflammatory cytokines TNF-α and IL-6 in animal models. However, there remains a paucity of information regarding Bacopa's potential as an anticancer agent, warranting further investigation in this domain. Based on previous findings with Brahmi (Bacopa monnieri), the current study aims to find out the role of Brahmi plant preparation (BPP) in immunomodulatory actions on IDC. Employing a specific BPP concentration, we conducted a comprehensive study using MTT assay, ELISA, DNA methylation analysis, Western blotting, ChIP, and mRNA profiling to assess BPP's immunomodulatory properties. Our research finding showed the role of BPP in augmenting the action of T helper 1 (T

Identifiants

pubmed: 38622289
doi: 10.1007/s12032-024-02365-x
pii: 10.1007/s12032-024-02365-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115

Subventions

Organisme : Science and Engineering Research Board
ID : ECR/2016/000965

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Basak A, Hossain ML, Parvin MN. Evaluation of phytochemical and pharmacological activities of Bacopa monnieri (L.). Int J Sci Rep. 2016;2(10):242.
doi: 10.18203/issn.2454-2156.IntJSciRep20163394
Nemetchek MD, Stierle AA, Stierle DB, Lurie DI. The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J Ethnopharmacol. 2017;197:92–100.
pubmed: 27473605 doi: 10.1016/j.jep.2016.07.073
Ghosh S, Khanam R, Acharya Chowdhury A. The evolving roles of Bacopa monnieri as potential anti-cancer agent: a review. Nutr Cancer. 2021;73(11–12):2166–76.
pubmed: 33148034 doi: 10.1080/01635581.2020.1841248
Mathur D, Goyal K, Koul V, Anand A. The molecular links of re-emerging therapy: a review of evidence of Brahmi (Bacopa monniera). Front Pharmacol. 2016;7:44.
pubmed: 26973531 pmcid: 4778428 doi: 10.3389/fphar.2016.00044
Singh HK, Dhawan BN. Effect of Bacopa monniera Linn.(Brāhmi) extract on avoidance responses in rat. J Ethnopharmacol. 1982;5(2):205–14.
pubmed: 7057659 doi: 10.1016/0378-8741(82)90044-7
Gohil KJ, Patel JA. A review on Bacopa monniera: current research and future prospects. Int J Green Pharm. 2010;4(1):1–9.
doi: 10.4103/0973-8258.62156
Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313–26.
pubmed: 23772955 pmcid: 3746283 doi: 10.1089/rej.2013.1431
Calabrese C, Gregory WL, Leo M, Kraemer D, Bone K, Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707–13.
pubmed: 18611150 pmcid: 3153866 doi: 10.1089/acm.2008.0018
Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12(4):305–17.
pubmed: 15898709 doi: 10.1016/j.phymed.2003.12.008
Sairam K, Dorababu M, Goel RK, Bhattacharya SK. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine. 2002;9(3):207–11.
pubmed: 12046860 doi: 10.1078/0944-7113-00116
Sairam K, Rao CV, Babu MD, Goel RK. Prophylactic and curative effects of Bacopa monniera in gastric ulcer models. Phytomedicine. 2001;8(6):423–30.
pubmed: 11824516 doi: 10.1078/S0944-7113(04)70060-4
Sinha S, Saxena R. Effect of iron on lipid peroxidation, and enzymatic and non-enzymatic antioxidants and bacoside-a content in medicinal plant Bacopa monnieri L. Chemosphere. 2006;62(8):1340–50.
pubmed: 16219336 doi: 10.1016/j.chemosphere.2005.07.030
Sharma GN, Dave R, Sanadya J, Sharma P, Sharma K. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res. 2010;1(2):109.
pubmed: 22247839 pmcid: 3255438
Agre AM, Upade AC, Yadav MA, Kumbhar SB. A review on breast cancer and its management. World J Pharm Res. 2021;10:408–37.
Shirode Nitesh G, Jadhav Sejal R. Breast cancer, factors influencing of it and management of breast cancer. World J Pharm Res. 2021;10:507–22.
Mersin H, Yıldırım E, Gülben K, Berberoğlu U. Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol. 2003;29(4):390–5.
pubmed: 12711296 doi: 10.1053/ejso.2002.1423
Du JR, Long FY, Chen C. Research progress on natural triterpenoid saponins in the chemoprevention and chemotherapy of cancer. Enzymes. 2014;36:95–130.
pubmed: 27102701 doi: 10.1016/B978-0-12-802215-3.00006-9
Palethorpe HM, Tomita Y, Smith E, Pei JV, Townsend AR, Price TJ, Young JP, Yool AJ, Hardingham JE. The aquaporin 1 inhibitor bacopaside II reduces endothelial cell migration and tubulogenesis and induces apoptosis. Int J Mol Sci. 2018;19(3):653.
pubmed: 29495367 pmcid: 5877514 doi: 10.3390/ijms19030653
Pei JV, Kourghi M, De Ieso ML, Campbell EM, Dorward HS, Hardingham JE, Yool AJ. Differential inhibition of water and ion channel activities of mammalian aquaporin-1 by two structurally related bacopaside compounds derived from the medicinal plant Bacopa monnieri. Mol Pharmacol. 2016;90(4):496–507.
pubmed: 27474162 doi: 10.1124/mol.116.105882
Peng L, Zhou Y, Kong DY, Zhang WD. Antitumor activities of dammarane triterpene saponins from Bacopa monniera. Phytother Res. 2010;24(6):864–8.
pubmed: 19960417 doi: 10.1002/ptr.3034
Smith E, Palethorpe HM, Tomita Y, Pei JV, Townsend AR, Price TJ, Young JP, Yool AJ, Hardingham JE. The purified extract from the medicinal plant Bacopa monnieri, bacopaside II, inhibits growth of colon cancer cells in vitro by inducing cell cycle arrest and apoptosis. Cells. 2018;7(7):81.
pubmed: 30037060 pmcid: 6070819 doi: 10.3390/cells7070081
Abid F, Saleem M, Zahid S, Arshad S, Yasir S, Qayyum M, Ashiq K, Tanveer S, Bajwa M, Ashiq S. A comprehensive review on anti-cancer medicinal plants. Int J Bot Stud. 2010;4:144–50.
Chandra S, Gahlot M, Choudhary AN, Palai S, de Almeida RS, de Vasconcelos JEL, dos Santos FAV, de Farias PAM, Coutinho HDM. Scientific evidences of anticancer potential of medicinal plants. Food Chem Adv. 2023. https://doi.org/10.1016/j.focha.2023.100239 .
doi: 10.1016/j.focha.2023.100239
Abdel-Moneim A, Magdy A. Review on medicinal plants as potential sources of cancer prevention and treatment. Eur J Biomed Pharm Sci. 2016;3(6):45–62.
Jonnalagadda B, Arockiasamy S, Vetrivel U, PA A. In silico docking of phytocompounds to identify potent inhibitors of signaling pathways involved in prostate cancer. J Biomol Struct Dyn. 2021;39(14):5182–208.
pubmed: 32643549 doi: 10.1080/07391102.2020.1785944
Sharma P, Kumar D, Shri R, Kumar S. Mechanistic insights and docking studies of phytomolecules as potential candidates in the management of cancer. Curr Pharm Des. 2022;28(33):2704–24.
pubmed: 35473540 doi: 10.2174/1381612828666220426112116
John S, Sivakumar KC, Mishra R. Bacoside a induces tumor cell death in human glioblastoma cell lines through catastrophic macropinocytosis. Front Mol Neurosci. 2017;10:171.
pubmed: 28663722 pmcid: 5471305 doi: 10.3389/fnmol.2017.00171
Aithal MG, Rajeswari N. Bacoside a induced sub-G0 arrest and early apoptosis in human glioblastoma cell line U-87 MG through notch signaling pathway. Brain Tumor Res Treat. 2019;7(1):25–32.
pubmed: 31062528 pmcid: 6504756 doi: 10.14791/btrt.2019.7.e21
Liu HY, Ji YL, Du H, Chen SH, Wang DP, Lv QL. Bacoside a inhibits the growth of glioma by promoting apoptosis and autophagy in U251 and U87 cells. Naunyn Schmiedebergs Arch Pharmacol. 2023. https://doi.org/10.1007/s00210-023-02724-x .
doi: 10.1007/s00210-023-02724-x pubmed: 38153514 pmcid: 10791733
Bandyopadhyay A, Garai S, Banerjee PP, Bhattacharya S, Chattopadhyay A. Bacopasaponins with cytotoxic activity against human breast cancer cells in vitro. Mol Biol Rep. 2021;48:2497–505.
pubmed: 33837902 doi: 10.1007/s11033-021-06284-2
Mallick MN, Akhtar MS, Najm MZ, Tamboli ET, Ahmad S, Husain SA. Evaluation of anticancer potential of Bacopa monnieri L. against MCF-7 and MDA-MB 231 cell line. J Pharm Bioallied Sci. 2015;7(4):325.
pubmed: 26681894 pmcid: 4678980 doi: 10.4103/0975-7406.168038
Palethorpe HM, Smith E, Tomita Y, Nakhjavani M, Yool AJ, Price TJ, Young JP, Townsend AR, Hardingham JE. Bacopasides I and II act in synergy to inhibit the growth, migration and invasion of breast cancer cell lines. Molecules. 2019;24(19):3539.
pubmed: 31574930 pmcid: 6803832 doi: 10.3390/molecules24193539
Fatima U, Roy S, Ahmad S, Ali S, Elkady WM, Khan I, Alsaffar RM, Adnan M, Islam A, Hassan MI. Pharmacological attributes of Bacopa monnieri extract: current updates and clinical manifestation. Front Nutr. 2022;9: 972379.
pubmed: 36061899 pmcid: 9436272 doi: 10.3389/fnut.2022.972379
Moskwa J, Naliwajko SK, Markiewicz-Żukowska R, Gromkowska-Kępka KJ, Nowakowski P, Strawa JW, Borawska MH, Tomczyk M, Socha K. Chemical composition of Polish propolis and its antiproliferative effect in combination with Bacopa monnieri on glioblastoma cell lines. Sci Rep. 2020;10(1):21127.
pubmed: 33273550 pmcid: 7712839 doi: 10.1038/s41598-020-78014-w
Girard N, Lou E, Azzoli CG, Reddy R, Robson M, Harlan M, Orlow I, Yatabe Y, Nafa K, Ladanyi M, Viale A. Analysis of genetic variants in never-smokers with lung cancer facilitated by an Internet-based blood collection protocol: a preliminary report. Clin Cancer Res. 2010;16(2):755–63.
pubmed: 20068085 pmcid: 2808124 doi: 10.1158/1078-0432.CCR-09-2437
Taylor MD, Sadhukhan S, Kottangada P, Ramgopal A, Sarkar K, D’Silva S, Selvakumar A, Candotti F, Vyas YM. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2(37):37ra44.
pubmed: 20574068 pmcid: 2943146 doi: 10.1126/scitranslmed.3000813
Baral R, Mandal I, Chattopadhyay U. Immunostimulatory neem leaf preparation acts as an adjuvant to enhance the efficacy of poorly immunogenic B16 melanoma surface antigen vaccine. Int Immunopharmacol. 2005;5(7–8):1343–52.
pubmed: 15914339 doi: 10.1016/j.intimp.2005.03.008
Sadhukhan S, Sarkar K, Taylor M, Candotti F, Vyas YM. Nuclear role of WASp in gene transcription is uncoupled from its ARP2/3-dependent cytoplasmic role in actin polymerization. J Immunol. 2014;193(1):150–60.
pubmed: 24872192 doi: 10.4049/jimmunol.1302923
Bhootra S, Jill N, Rajak R, Shanmugam G, Rakshit S, Kannanthodi S, Thakkar V, George M, Sarkar K. Diospyros malabarica fruit preparation mediates immunotherapeutic modulation and epigenetic regulation to evoke protection against non–small cell lung cancer (NSCLC). J Ethnopharmacol. 2023;314: 116525.
pubmed: 37149067 doi: 10.1016/j.jep.2023.116525
Pal R, Rakshit S, Shanmugam G, Paul N, Bhattacharya D, Chatterjee A, Singh A, George M, Sarkar K. Involvement of Xeroderma Pigmentosum Complementation Group G (XPG) in epigenetic regulation of T-Helper (TH) cell differentiation during breast cancer. Immunobiology. 2022;227(5): 152259.
pubmed: 36037675 doi: 10.1016/j.imbio.2022.152259
Sarkar K, Sadhukhan S, Han SS, Vyas YM. SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells. Blood. 2015;126(14):1670–82.
pubmed: 26261240 pmcid: 4591791 doi: 10.1182/blood-2015-05-646182
Kurien BT, Scofield RH. Western blotting: an introduction. Western blotting: methods and protocols. 2015. https://doi.org/10.1007/978-1-4939-2694-7_5 .
doi: 10.1007/978-1-4939-2694-7_5
Chatterjee A, Singh A, Shanmugam G, Rakshit S, Mohanty LM, Kumar A, Harihar S, Sarkar K. Neem leaf glycoprotein mediated epigenetic modification in oral squamous cell carcinoma. Phytomed Plus. 2023;3(1): 100400.
doi: 10.1016/j.phyplu.2022.100400
Bose A, Chakraborty K, Sarkar K, Goswami S, Chakraborty T, Pal S, Baral R. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNγ signaling. J Immunother. 2009;32(1):42–53.
pubmed: 19307993 doi: 10.1097/CJI.0b013e31818e997d
Swaroop AK, Lalitha CMVN, Shanmugam M, Subramanian G, Natarajan J, Selvaraj J. Plant derived immunomodulators; a critical review. Adv Pharm Bull. 2022;12(4):712.
pubmed: 36415638
Dar KB, Khan IS, Amin S, Ganie AH, Bhat AH, Dar SA, Reshi BA, Ganie SA. Active cousinia thomsonii extracts modulate expression of crucial proinflammatory mediators/cytokines and NFκB cascade in lipopolysaccharide-induced albino wistar rat model. J Inflamm Res. 2020;13:829–45.
pubmed: 33173324 pmcid: 7646511 doi: 10.2147/JIR.S272539
Özenver N, Efferth T. Evaluation of immunomodulatory potential of medicinal plants—present scenario. In: Evidence-based validation of herbal medicine. Elsevier; 2022. p. 487–500.
doi: 10.1016/B978-0-323-85542-6.00022-6
Zebeaman M, Tadesse MG, Bachheti RK, Bachheti A, Gebeyhu R, Chaubey KK. Plants and plant-derived molecules as natural immunomodulators. Biomed Res Int. 2023. https://doi.org/10.1155/2023/7711297 .
doi: 10.1155/2023/7711297 pubmed: 37313550 pmcid: 10260316
Bashir Dar K, Hussain Bhat A, Amin S, Masood A, Afzal Zargar M, Ahmad Ganie S. Inflammation: a multidimensional insight on natural anti-inflammatory therapeutic compounds. Curr Med Chem. 2016;23(33):3775–800.
doi: 10.2174/0929867323666160817163531
Deb DD, Kapoor P, Dighe RP, Padmaja R, Anand MS, D’souza P, Deepak M, Murali B, Agarwal A. In vitro safety evaluation and anticlastogenic effect of BacoMind™ on human lymphocytes. Biomed Environ Sci. 2008;21(1):7–23.
pubmed: 18478974 doi: 10.1016/S0895-3988(08)60002-1
Mishra S, Yadav A, Rajan N. Medicinal uses of Brahmi. In: Traditional utilization and pharmacological properties of medicinal plants. Scripown Publications; 2021. p. 14.

Auteurs

Sohini Roy (S)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

Geetha Shanmugam (G)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

Sudeshna Rakshit (S)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

R Pradeep (R)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

Melvin George (M)

Department of Clinical Pharmacology, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India.

Koustav Sarkar (K)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Chennai, Tamil Nadu, 603203, India. koustavsarkar@gmail.com.

Classifications MeSH